ID

34273

Description

Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin; ODM derived from: https://clinicaltrials.gov/show/NCT02111967

Lien

https://clinicaltrials.gov/show/NCT02111967

Mots-clés

  1. 16/01/2019 16/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

16 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus Type 2 NCT02111967

Eligibility Diabetes Mellitus Type 2 NCT02111967

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of t2dm > 6 months
Description

ID.1

Type de données

boolean

metformin treatment for at least 6 months
Description

ID.2

Type de données

boolean

age > 18 years
Description

ID.3

Type de données

boolean

ability to give written informed consent
Description

ID.4

Type de données

boolean

no metformin treatment in the last 6 months (control group)
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
concurrent intake of preparations containing vb12 (within the last 3 months prior to study participation)
Description

ID.6

Type de données

boolean

lack of written and/or oral understanding in german, french, italian or english languages
Description

ID.7

Type de données

boolean

diagnosis of transcobolamin transporter defect
Description

ID.8

Type de données

boolean

diagnosis of chronic or acute liver diseaseliver insufficiency with child-pugh scores b and c and acute hepatitis
Description

ID.9

Type de données

boolean

diagnosis of renal disease (creatinine-clearance <60 ml/min)renal insufficiency stadium iii, iv and v (kdoqi) and acute renal diseases
Description

ID.10

Type de données

boolean

Similar models

Eligibility Diabetes Mellitus Type 2 NCT02111967

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosis of t2dm > 6 months
boolean
ID.2
Item
metformin treatment for at least 6 months
boolean
ID.3
Item
age > 18 years
boolean
ID.4
Item
ability to give written informed consent
boolean
ID.5
Item
no metformin treatment in the last 6 months (control group)
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
concurrent intake of preparations containing vb12 (within the last 3 months prior to study participation)
boolean
ID.7
Item
lack of written and/or oral understanding in german, french, italian or english languages
boolean
ID.8
Item
diagnosis of transcobolamin transporter defect
boolean
ID.9
Item
diagnosis of chronic or acute liver diseaseliver insufficiency with child-pugh scores b and c and acute hepatitis
boolean
ID.10
Item
diagnosis of renal disease (creatinine-clearance <60 ml/min)renal insufficiency stadium iii, iv and v (kdoqi) and acute renal diseases
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial